메뉴 건너뛰기
New England Journal of Medicine
Volumn 369, Issue 17, 2013, Pages 1659-1660
Radium-223 in prostate cancer
Author keywords

[No Author keywords available]
Indexed keywords

PLACEBO; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; RADIUM 223; RHENIUM 188; UNCLASSIFIED DRUG; RADIUM;
EID: 84886260593     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1310231     Document Type: Letter
Times cited : (18)
References (5)
  • 1
    • 84880416044 scopus 로고    scopus 로고
    • Fighting prostate cancer with radium-223 - not your Madame's isotope
    • Vapiwala N, Glatstein E. Fighting prostate cancer with radium-223 - not your Madame's isotope. N Engl J Med 2013;369:276-8.
    • (2013) N Engl J Med , vol.369 , pp. 276-278
    • Vapiwala, N.1    Glatstein, E.2
  • 2
    • 84880428467 scopus 로고    scopus 로고
    • Alpha emitter radium-223 and survival in metastatic prostate cancer
    • Parker C, Nilsson S, Heinrich D, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med 2013;369:213-23.
    • (2013) N Engl J Med , vol.369 , pp. 213-223
    • Parker, C.1    Nilsson, S.2    Heinrich, D.3
  • 3
    • 0042887586 scopus 로고    scopus 로고
    • Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: Randomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate
    • Palmedo H, Manka-Waluch A, Albers P, et al. Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: randomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate. J Clin Oncol 2003;21:2869-75.
    • (2003) J Clin Oncol , vol.21 , pp. 2869-2875
    • Palmedo, H.1    Manka-Waluch, A.2    Albers, P.3
  • 4
    • 80455127104 scopus 로고    scopus 로고
    • Palliation and survival after repeated (188)Re-HEDP therapy of hormone-refractory bone metastases of prostate cancer: A retrospective analysis
    • Biersack H-J, Palmedo H, Andris A, et al. Palliation and survival after repeated (188)Re-HEDP therapy of hormone-refractory bone metastases of prostate cancer: a retrospective analysis. J Nucl Med 2011;52:1721-6.
    • (2011) J Nucl Med , vol.52 , pp. 1721-1726
    • Biersack, H.-J.1    Palmedo, H.2    Andris, A.3
  • 5
    • 0032053423 scopus 로고    scopus 로고
    • Reactor-produced radioisotopes from ORNL for bone pain palliation
    • Knapp FF Jr, Mirzadeh S, Beets AL, et al. Reactor-produced radioisotopes from ORNL for bone pain palliation. Appl Radiat Isot 1998;49:309-15.
    • (1998) Appl Radiat Isot , vol.49 , pp. 309-315
    • Knapp Jr., F.F.1    Mirzadeh, S.2    Beets, A.L.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.